低禁食血葡萄糖水平作为心血管疾病和所有原因死亡率的预测因素
M Wei1, L W Gibbons, T L Mitchell
1Cooper Institute, Dallas, TX 75230, USA. mwei@cooperinst.org
Circulation
|May 3, 2000
概括
低禁食血葡萄糖,以前不被认为是危险因素,显著增加心血管疾病和所有原因的死亡风险. 这一发现挑战了对异常葡萄糖水平的传统医学分类.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 流行病学 流行病学
背景情况:
- 医学教科书通常将不正常的禁食血葡萄糖 (FPG) 定义为<70或<80 mg/dL.
- 低FPG水平的临床意义和预后影响仍然不清楚.
研究的目的:
- 调查低禁食血葡萄糖水平与心血管疾病 (CVD) 死亡率和所有原因死亡率的风险之间的联系.
主要方法:
- 未来的队列研究涉及40069名参与者.
- 分析调整了许多人口,临床和生活方式因素.
- 评估FPG水平与死亡结果之间的关系.
主要成果:
- 在FPG水平和死亡率之间观察到U形关系.
- 低FPG (<70 mg/dL) 与心血管疾病死亡率增加3.3倍的风险有关.
- 与80-109 mg/dL的FPG相比,70-79 mg/dL的FPG水平显示心血管疾病死亡风险增加了2.4倍.
- 低FPG水平也与所有原因死亡率的增加有显著联系.
结论:
- 低禁食血葡萄糖水平代表了心血管疾病和全因死亡的重大风险因素.
- 这些发现需要重新评估诊断标准和低FPG的临床管理.
更多相关视频
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
